Acemetacin
From Wikipedia, the free encyclopedia
 |
|
|
Acemetacin
|
|
| Systematic (IUPAC) name | |
| 2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid | |
| Identifiers | |
| CAS number | |
| ATC code | M01 |
| PubChem | |
| Chemical data | |
| Formula | C21H18ClNO6 |
| Mol. mass | 415.82372 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Acemetacin is a non-steroidal anti-inflammatory drug. It is a Glycolic acid ester of Indometacin. It is manufactured by Merck under the tradename Emflex, and is available in the UK as a prescription-only drug.
|
|||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
